We help people to lose weight.
A new, innovative, and outpatient weight-loss therapy for the treatment of obesity.
Freezing the hunger feeling.
20 minutes will change your life – a fast and uncomplicated therapy.
Just a short, one-off, minimally invasive cryo-ablation procedure. But the feeling of hunger is permanently reduced in the long term.
About us.
Our business: a new interventional weight-loss therapy.
A team of experienced engineers and physicians is developing a medical device for a minimally invasive, outpatient, interventional treatment of obesity.
The therapy is easy to execute without major risks or major side effects.
A prototype has been developed and successfully tested for safety and efficacy.
Several awards and prizes confirm our innovative approach.
About obesity.
The world is getting fatter. Fast.
Obesity is a serious disease. It causes a variety of secondary diseases such as diabetes, stroke and 13 different types of cancer. The cost to the healthcare system increases by 40% because one in five people is obese.
Forecasts of obesity market revenues (USD by 2030)
Our therapy.
Freezing the hunger feeling.
We have developed a medical device for a one-time, interventional therapy. By this office-based procedure a long-term reduction of the hunger feeling will be achieved. The gastric trunks of the vagus nerve conveying the hunger feeling to the brain are disrupted by the proven technology of cryo-ablation.
Milestones.
The therapy of Sedivention is presented at the
European Congress on Obesity (EASO 2025) (ES)
Medtech Bridge (USA) awards Sedivention
for its accelerator program
NOME (DK) (Nordic Mentor Network for Entrepreneurship) awards Sedivention
for its mentoring program 25/26
Refinement of the commercial stategy with the ESMT (European School of Management and Technology) (GER)
Sedivention files two more patents
TUM (Technical University of Munich) (GER) project: business modelling, market potential, and network for obesity
NOME (DK) (Nordic Mentor Network for Entrepreneurship) supported by Novo Nordisk Foundation (DK) awards Sedivention for its pitch competition
Proof of concept demonstrated and prototype successfully tested: safety and effectiveness of therapy verified – ETH Zuerich (CH) and CV Path Institute (USA)
CDL (Creative Destruction Lab) (CAN) awards Sedivention for its mentoring program 24/25
HTGF (High-tech Gruenderfonds) (GER)
invests in Sedivention
Second generation of the prototype (Blizzard Catheter) is completed
Sedivention wins the Science4Life Venture Cup (GER)
Sedivention wins three awards from BayStartUp
Third patent filed by Sedivention
First generation of the prototype (Blizzard Catheter) is completed
Bayern Innovativ (GER) funds
Sedivention with three grants
Sedivention GmbH is founded
First patent granted
Two patents filed
Awards:
Winner in all three phases of the Business Plan Competition 2023
Winner of the
Venture Cup 2023
Accelerators:
Memberships:
Grants:
Investors:
Our team.
We are start-ups – but not beginners.
At sedivention, we are an optimal mix of highly experienced specialists –
physicians, engineers, and MedTech managers.
Dr.-Ing. Andreas Bröcker
CEO
Co-Founder
Dr. med. Ute Nollert
CMO
Founder
André Burch, EMBA
Co-Founder
Ann-Kathrin Waldmann
Business Development /
Business Intelligence
Jakob Wintermeyer
Corporate Fundraising /
Investor Management
Sara Nehmeier
Marketing Manager /
sedivention Platform
News.
Stay tuned.
Literature.
Get more informations.